XML 40 R28.htm IDEA: XBRL DOCUMENT v3.25.3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

9 Months Ended

Sep. 30, 2025

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Schedule of allowance for credit losses

		September 30, 2025  (Unaudited)				December 31, 2024
Allowance for credit losses		$	2,229,977			$	1,494,347
Credit loss expense			197,639				1,050,543
Adjustment for uncollectible accounts			(1,236,069	)			(314,913	)
Allowance for credit losses		$	1,191,547			$	2,229,977

Schedule of earnings per share

		For the three months ended
		September 30,
		(Unaudited)
		2025				2024
Net Income (Loss)		$	(450,348	)		$	58,962
Adjustments for convertible debt - as converted:			-				-
Interest on convertible debt net of effective tax rate (28%)			-				-
Net income (loss) attributable to common shareholders		$	(450,348	)		$	58,962
Weighted average number of shares of common stock outstanding:
Basic			20,075,205				20,015,205
Diluted			20,075,205				20,096,751
Net income (loss) attributable to common shareholders per share:
Basic		$	(0.02	)		$	0.00
Diluted		$	(0.02	)		$	0.00

Schedule of anti-dilutive securities

		For the three months ended
		September 30,
		(Unaudited)
		2025				2024
Numerator:
Net Income (Loss)		$	(450,348	)		$	58,962
Denominator:
Basic weighted-average shares			20,075,205				20,015,205
Effect of dilutive securities
Warrants			-				5,908
Convertible Debt			-				-
Options			-				11,888
Preferred Stock			-				63,750
Diluted Weighted Average Shares			20,075,205				20,096,751
Net income (loss) attributable to common shareholders per share:
Basic		$	(0.02	)		$	0.00
Diluted		$	(0.02	)		$	0.00

		For the three months ended
		September 30,
		(Unaudited)
		2025				2024
Options			768,792				573,000
Warrants			2,604,388				2,734,596
Convertible Debt			2,508,000				2,080,000
Total anti-dilutive shares			5,881,180				5,387,596

Schedule of disaggregation of revenue

		For the three months ended September 30, (Unaudited)
		2025				2024
SteraMist Product		$	1,603,000			$	1,766,000
Service and Training			409,000				776,000
Total		$	2,012,000			$	2,542,000

		For the three months ended September 30, (Unaudited)
		2025				2024
United States		$	1,280,000			$	1,886,000
International			732,000				656,000
Total		$	2,012,000			$	2,542,000

		For the nine months ended September 30, (Unaudited)
		2025				2024
SteraMist Product		$	3,255,000			$	5,247,000
Service and Training			1,364,000				1,423,000
Total		$	4,619,000			$	6,670,000

		For the nine months ended September 30, (Unaudited)
		2025				2024
United States		$	3,294,000			$	5,169,000
International			1,325,000				1,501,000
Total		$	4,619,000			$	6,670,000

X

- References

No definition available.

+ Details

Name:	tomz_ScheduleOfAllowanceForCreditLossesTableTextBlock
Namespace Prefix:	tomz_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_AccountingPoliciesAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-5

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration